Coenzyme Common Stock from 2010 to 2026

PPII Stock  USD 0.0002  0.00  0.00%   
Coenzyme A's Common Stock is increasing with slightly volatile movements from year to year. Common Stock is predicted to flatten to about 54 K. For the period between 2010 and 2026, Coenzyme A, Common Stock quarterly trend regression had mean deviation of  1,196 and range of 18.4 K. View All Fundamentals
 
Common Stock  
First Reported
2010-12-31
Previous Quarter
62.3 K
Current Value
54 K
Quarterly Volatility
3.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Coenzyme A financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Coenzyme A's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 272.8 K or Total Revenue of 316.4 K, as well as many indicators such as . Coenzyme financial statements analysis is a perfect complement when working with Coenzyme A Valuation or Volatility modules.
  
Build AI portfolio with Coenzyme Stock
Check out the analysis of Coenzyme A Correlation against competitors.
For more detail on how to invest in Coenzyme Stock please use our How to Invest in Coenzyme A guide.
The Common Stock trend for Coenzyme A offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Coenzyme A is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Coenzyme A's Common Stock Growth Pattern

Below is the plot of the Common Stock of Coenzyme A over the last few years. It is Coenzyme A's Common Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Coenzyme A's overall financial position and show how it may be relating to other accounts over time.
Common Stock10 Years Trend
Slightly volatile
   Common Stock   
       Timeline  

Coenzyme Common Stock Regression Statistics

Arithmetic Mean54,044
Geometric Mean53,947
Coefficient Of Variation6.04
Mean Deviation1,196
Median54,180
Standard Deviation3,264
Sample Variance10.7M
Range18.4K
R-Value0.52
Mean Square Error8.3M
R-Squared0.27
Significance0.03
Slope335.93
Total Sum of Squares170.4M

Coenzyme Common Stock History

202654 K
202562.3 K
201154.2 K
201044 K

About Coenzyme A Financial Statements

Investors use fundamental indicators, such as Coenzyme A's Common Stock, to determine how well the company is positioned to perform in the future. Although Coenzyme A's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Common Stock62.3 K54 K

Currently Active Assets on Macroaxis

When determining whether Coenzyme A offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Coenzyme A's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Coenzyme A Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Coenzyme A Stock:
Check out the analysis of Coenzyme A Correlation against competitors.
For more detail on how to invest in Coenzyme Stock please use our How to Invest in Coenzyme A guide.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is there potential for Pharmaceuticals market expansion? Will Coenzyme introduce new products? Factors like these will boost the valuation of Coenzyme A. Anticipated expansion of Coenzyme directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Coenzyme A listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(35.31)
Revenue Per Share
2.652
Quarterly Revenue Growth
0.268
Coenzyme A's market price often diverges from its book value, the accounting figure shown on Coenzyme's balance sheet. Smart investors calculate Coenzyme A's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Coenzyme A's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Coenzyme A's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Coenzyme A should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Coenzyme A's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.